DE2636328A1 - Arzneimittel - Google Patents

Arzneimittel

Info

Publication number
DE2636328A1
DE2636328A1 DE19762636328 DE2636328A DE2636328A1 DE 2636328 A1 DE2636328 A1 DE 2636328A1 DE 19762636328 DE19762636328 DE 19762636328 DE 2636328 A DE2636328 A DE 2636328A DE 2636328 A1 DE2636328 A1 DE 2636328A1
Authority
DE
Germany
Prior art keywords
component
hydrazino
medicament according
methyl
dihydroxyphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19762636328
Other languages
German (de)
English (en)
Inventor
Alexander Scriabine
Clement Addison Stone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE2636328A1 publication Critical patent/DE2636328A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE19762636328 1975-08-13 1976-08-12 Arzneimittel Withdrawn DE2636328A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/604,292 US4016288A (en) 1975-08-13 1975-08-13 Compositions and method of treating hypertension

Publications (1)

Publication Number Publication Date
DE2636328A1 true DE2636328A1 (de) 1977-02-24

Family

ID=24419029

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762636328 Withdrawn DE2636328A1 (de) 1975-08-13 1976-08-12 Arzneimittel

Country Status (10)

Country Link
US (1) US4016288A (enExample)
JP (1) JPS5225035A (enExample)
AU (1) AU508424B2 (enExample)
BE (1) BE845117A (enExample)
CA (1) CA1069825A (enExample)
DE (1) DE2636328A1 (enExample)
FR (1) FR2320738A1 (enExample)
GB (1) GB1505959A (enExample)
NL (1) NL7608381A (enExample)
ZA (1) ZA764852B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670578A (en) * 1983-08-29 1987-06-02 Merck & Co., Inc. Process for crystalline salts of L or (S)-3-(3,4-dihydroxyphenyl)-2-methylalanine esters
US20050136103A1 (en) * 2003-09-17 2005-06-23 Ben-Sasson Shmuel A. Compositions capable of facilitating penetration across a biological barrier
TWI755257B (zh) * 2014-10-21 2022-02-11 美商艾伯維有限公司 卡比多巴及左旋多巴之前藥及使用方法
CN111588833A (zh) * 2020-07-09 2020-08-28 北京大元藏宝堂健康管理有限公司 一种调节高血压的产品

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3784703A (en) * 1972-02-29 1974-01-08 Merck & Co Inc Method of treating hypertension
US3830827A (en) * 1970-03-23 1974-08-20 Merck & Co Inc L-alpha-hydrazino-alpha-substituted-beta-(3,4-dihydroxyphenyl)propionic acid substantially free of the d isomer,the lower alkyl esters thereof,and the pharmaceutically acceptable salts thereof,wherein the substituent is lower alkyl

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3839585A (en) * 1970-08-05 1974-10-01 Merck & Co Inc Method of treating hypertension
AU464903B2 (en) * 1970-11-12 1975-09-11 Merck & Co., Inc Treatment of hypertension
US3795739A (en) * 1972-02-14 1974-03-05 Hoffmann La Roche Treatment of parkinson disease

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3830827A (en) * 1970-03-23 1974-08-20 Merck & Co Inc L-alpha-hydrazino-alpha-substituted-beta-(3,4-dihydroxyphenyl)propionic acid substantially free of the d isomer,the lower alkyl esters thereof,and the pharmaceutically acceptable salts thereof,wherein the substituent is lower alkyl
US3784703A (en) * 1972-02-29 1974-01-08 Merck & Co Inc Method of treating hypertension

Also Published As

Publication number Publication date
ZA764852B (en) 1978-03-29
US4016288A (en) 1977-04-05
CA1069825A (en) 1980-01-15
AU508424B2 (en) 1980-03-20
NL7608381A (nl) 1977-02-15
AU1655876A (en) 1978-02-09
FR2320738B1 (enExample) 1979-05-18
FR2320738A1 (fr) 1977-03-11
JPS5225035A (en) 1977-02-24
BE845117A (fr) 1977-02-14
GB1505959A (en) 1978-04-05

Similar Documents

Publication Publication Date Title
DE3586545T2 (de) Erhoehte schmerzlosigkeit bewirkende pharmazeutische zusammensetzungen.
DE4122166A1 (de) Verwendung des wirkstoffs flupirtin zur bekaempfung von muskelverspannungen
AT401468B (de) Pharmazeutische zusammensetzungen mit einem gehalt an ranitidinwismutcitrat
DE3786893T2 (de) Piperidinderivat zur Schmerzbehandlung.
EP0675717A1 (de) Verwendung von 2-amino-6-a-propyl-amino-4,5,6,7-tetrahydrobenzothiazol (pramipexol) als arzneimittel mit antidepressiver wirkung
DE1802394C2 (de) Arzneimittel mit antihypertensiver Wirkung, die [(2,6-Dichlorbenzyliden)-amino]-guanidin oder ein Säureadditionssalz davon enthalten
DE69420776T2 (de) Idebenone-haltige Zusammensetzungen zur Behandlung von M. Alzheimer
DE69824313T2 (de) Sibutramin und orlistat enthaltende pharmazeutische zusammensetzungen
DE3343934A1 (de) M-chlor-(alpha)-tert.-butylaminopropiophenon und seine verwendung zur senkung des cholesterolspiegels
DE69131398T2 (de) Verwendung von 5-ht4 rezeptorantagonisten zur behandlung von vorhof-fibrillation und zur vorbeugung von schlaganfall
DE68915269T2 (de) Polyvalentes entzündungshemmendes mittel.
DE3035494A1 (de) Carnitin enthaltendes arzneimittel zur behandlung von hyperlipidaemie und hyperlipoproteinaemie, sowie verwendung von carnitin zur herstellung eines solchen arzneimittels
DE69529819T2 (de) Neue kombination eines betablockers mit einem lokalanästhetikum
DE69522764T2 (de) Verwendung vom einem Bicycloheptan-Derivat
EP0132595B1 (de) Tokolytisches Mittel
DE2636328A1 (de) Arzneimittel
CH642542A5 (de) Arzneimittel, enthaltend eine kombination aus einem prolinderivat und einem diuretikum.
EP0524512B1 (de) Antihypertensive Kombination
DE69022206T2 (de) Aldosereduktasehemmer enthaltende Zubereitungen zur Behandlung von Geschwüren.
EP0471388A2 (de) Mittel zur Behandlung der Herzinsuffizienz
DE3887426T2 (de) Eperisone als Hypotonikum.
EP0192098B1 (de) Verwendung des 2-Amino-6-allyl-5,6,7,8-tetrahydro-4H-thiazolo[4,5-d]azepins zur Herstellung eines zur Behandlung der Parkinsonschen Erkrankung bzw. des Parkinsonismus geeigneten Arzneimittels
DE69302250T2 (de) Verwendung von Isoquinolinon-Derivaten zur Behandlung von Hyperlipoproteinemia
DE2131616A1 (de) Pharmazeutisches Praeparat
DE2351609A1 (de) Neue pharmazeutische zubereitungen

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8128 New person/name/address of the agent

Representative=s name: ABITZ, W., DIPL.-ING.DR.-ING. MORF, D., DR., PAT.-

8136 Disposal/non-payment of the fee for publication/grant